Denis Kachanov
Overview
Explore the profile of Denis Kachanov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flaadt T, Lemelle L, Abele M, Virgone C, Ben-Ami T, Kachanov D, et al.
Lung Cancer
. 2025 Feb;
201:108449.
PMID: 39999637
Background And Aims: NUT carcinoma (NC) is a sporadic, highly aggressive tumor that primarily affects children, adolescents, and young adults and is characterized by the presence of somatic NUTM1 rearrangements....
2.
Schultz K, Nelson A, Mallinger P, Harris A, Kamihara J, Baldinger S, et al.
Clin Cancer Res
. 2024 Oct;
30(24):5681-5692.
PMID: 39400264
Purpose: DICER1-related tumor predisposition increases risk for a spectrum of benign and malignant tumors. In 2018, the International Pleuropulmonary Blastoma (PPB)/DICER1 Registry published guidelines for testing- and imaging-based surveillance of...
3.
Chaurasiya K, Kireeva E, Shamanskaya T, Kachanov D, Likar Y
Clin Nucl Med
. 2023 Apr;
48(6):e316-e317.
PMID: 37083676
Primary neuroblastoma is the most common extracranial solid tumor in children and may occur anywhere along the sympathetic chain, but most commonly occur in abdominal/retroperitoneal region including the adrenal glands,...
4.
Sorrentino S, Ash S, Haupt R, Plantaz D, Schiff I, Hero B, et al.
Front Pediatr
. 2022 Oct;
10:1023498.
PMID: 36299690
Introduction: Between 5 and 15% of children with neuroblastoma (NB) present with or develop spinal canal invasion (SCI). The majority of these children have symptoms of epidural compression of spinal...
5.
Yadgarov M, Kailash C, Shamanskaya T, Kachanov D, Likar Y
Pediatr Blood Cancer
. 2022 Jun;
69(11):e29849.
PMID: 35727712
Background: In recent years, many research groups have attempted to identify a subgroup of "ultra-high risk" patients within the high-risk neuroblastoma (NB) category. The aim of our study was to...
6.
Nemes K, Johann P, Steinbugl M, Gruhle M, Bens S, Kachanov D, et al.
Cancers (Basel)
. 2022 May;
14(9).
PMID: 35565313
Malignant rhabdoid tumors (MRT) predominantly affect infants and young children. Patients below six months of age represent a particularly therapeutically challenging group. Toxicity to developing organ sites limits intensity of...
7.
Surun A, Schneider D, Ferrari A, Stachowicz-Stencel T, Rascon J, Synakiewicz A, et al.
Pediatr Blood Cancer
. 2021 Jun;
68 Suppl 4:e29058.
PMID: 34174160
Salivary gland carcinomas (SGCs) are rare during childhood and adolescence. Consequently, no standardized recommendations for the diagnosis and therapeutic management of pediatric SGC are available, and pediatric oncologists and surgeons...
8.
Bien E, Roganovic J, Krawczyk M, Godzinski J, Orbach D, Cecchetto G, et al.
Pediatr Blood Cancer
. 2021 Jun;
68 Suppl 4:e29112.
PMID: 34174157
Pancreatoblastoma (PBL) is a rare malignant epithelial neoplasm that affects typically young children. Signs related to advanced upper-abdominal tumor accompanied by elevated serum α-fetoprotein levels in a young child suggest...
9.
Nemes K, Bens S, Kachanov D, Teleshova M, Hauser P, Simon T, et al.
Eur J Cancer
. 2020 Nov;
142:112-122.
PMID: 33249395
Introduction: Extracranial rhabdoid tumours are rare, highly aggressive malignancies primarily affecting young children. The EU-RHAB registry was initiated in 2009 to prospectively collect data of rhabdoid tumour patients treated according...
10.
Karalexi M, Servitzoglou M, Moschovi M, Moiseenko R, Bouka P, Ntzani E, et al.
Cancer Epidemiol
. 2020 Nov;
70:101850.
PMID: 33220637
Background: Despite overall striking advances in survival of childhood liver tumors, outcomes remain poor for specific patient segments. We aimed to assess overall survival (OS) of this rare disease and...